September is Childhood Cancer Awareness Month — a reminder that every child’s fight deserves global urgency. This year, Shir for Life marked the month in two important ways: hosting our September 5th webinar with Dr. Lucas Moreno, President of SIOPEN, and later joining the international neuroblastoma community at the SIOPEN annual conference in Copenhagen.

A conversation with Dr. Michael LaQuaglia, Chief of Pediatric Surgery at Memorial Sloan Kettering When a child is diagnosed with neuroblastoma, surgery is often one of the first things families ask about. What kind of surgery will be needed? Can the tumor be fully removed? What are the risks—and what comes next?

For families navigating a neuroblastoma diagnosis, one of the most confusing aspects is understanding the difference between stage and risk classification. Many assume that all Stage 4 neuroblastoma cases are the same, but the reality is much more complex—and personal.